[Malignant melanoma with anaplastic lymphoma kinase positivity: a clinicopathological analysis of three cases].

PubMed 2026

View at publisher
Authors: Z Chen, H J Yang, H Cao, L M Xu, X D Teng
DOI: 10.3760/cma.j.cn112151-20251007-00662
Cited by: 0

Abstract

Both ALK fusion and ATI-driven ALK expression patterns can present in malignant melanomas. Aberrant ALK activation suggests its potential role in molecular pathogenesis of malignant melanoma. Further investigation of ALK as a therapeutic target seems necessary.

Fields of Study & Subjects

Cutaneous Melanoma Detection and Management Melanoma and MAPK Pathways Cutaneous lymphoproliferative disorders research

Publication details

Journal / source
PubMed
Volume
55
Issue
1
Pages
28–33
Publication date
8 January 2026
Language
ZH